Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 925 to 974 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 925\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent [pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial precursor (ec 2.7.1.99) (pyruvate dehydrogenase kinase isoform 1). [source:swissprot;acc:q15118]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5637.43\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6193.07\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.09856\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 926\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent [pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial precursor (ec 2.7.1.99) (pyruvate dehydrogenase kinase isoform 2). [source:swissprot;acc:q15119]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5637.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6193.08\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 927\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dipeptidylpeptidase 10; dipeptidyl peptidase iv-related protein 3. [source:refseq;acc:nm\_020868]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5638.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6194.22\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.09853\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 928\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cytochrome c oxidase assembly protein cox11, mitochondrial precursor. [source:swissprot;acc:q9y6n1]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5638.46\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6194.04\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 929\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent surfeit locus protein 1. [source:swissprot;acc:q15526]\vspace{3pt}}&&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 930\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dipeptidyl aminopeptidase-like protein 6 (dipeptidylpeptidase vi) (dipeptidylpeptidase 6) (dipeptidyl peptidase iv like protein) (dipeptidyl aminopeptidase-related protein) (dppx). [source:swissprot;acc:p42658]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5638.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6194.23\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 931\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent seprase (ec 3.4.21.-) (fibroblast activation protein alpha) (integral membrane serine protease) (170-kda melanoma membrane-bound gelatinase). [source:swissprot;acc:q12884]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5638.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6194.17\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 932\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cox15 homolog isoform 2 precursor; cytochrome c oxidase subunit 15; cytochrome c oxidase assembly protein. [source:refseq;acc:nm\_004376]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5638.46\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6194.04\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 933\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protoheme ix farnesyltransferase, mitochondrial precursor (ec 2.5.1.-) (heme o synthase). [source:swissprot;acc:q12887]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 934\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent [3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial precursor (ec 2.7.1.115) (branched-chain alpha-ketoacid dehydrogenase kinase) (bckdhkin) (bckd-kinase). [source:swissprot;acc:o14874]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5640\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6195.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0985\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 935\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent neurotrimin precursor (hnt). [source:swissprot;acc:q9p121]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5413.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5946.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.09842\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 936\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nif3-like protein 1 (amyotrophic lateral sclerosis 2 chromosomal region candidate gene protein 1) (my018 protein) (mds015). [source:swissprot;acc:q9gzt8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5628.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6180.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.09811\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 937\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nucleobindin 1 precursor (calnuc). [source:swissprot;acc:q02818]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5859.25\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6432.03\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.09776\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 938\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dna mismatch repair protein mlh1 (mutl protein homolog 1). [source:swissprot;acc:p40692]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 939\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nucleobindin 2 precursor (dna-binding protein nefa). [source:swissprot;acc:p80303]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 940\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent adenosylhomocysteinase (ec 3.3.1.1) (s-adenosyl-l-homocysteine hydrolase) (adohcyase). [source:swissprot;acc:p23526]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5568.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6113.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.09775\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 941\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent caax prenyl protease 1 homolog (ec 3.4.24.-) (prenyl protein-specific endoprotease 1) (farnesylated-proteins converting enzyme 1) (face-1) (zinc metalloproteinase ste24 homolog). [source:swissprot;acc:o75844]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4970.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5455.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.09761\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 942\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent phosphoglycerate kinase, testis specific (ec 2.7.2.3). [source:swissprot;acc:p07205]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6597.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7240.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.09747\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 943\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma enolase (ec 4.2.1.11) (2-phospho-d-glycerate hydro-lyase) (neural enolase) (nse) (enolase 2). [source:swissprot;acc:p09104]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6597.98\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 7241\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.09746\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 944\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent beta enolase (ec 4.2.1.11) (2-phospho-d-glycerate hydro-lyase) (skeletal muscle enolase) (mse) (enolase 3). [source:swissprot;acc:p13929]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 945\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent alpha enolase (ec 4.2.1.11) (2-phospho-d-glycerate hydro-lyase) (non- neural enolase) (nne) (enolase 1) (phosphopyruvate hydratase). [source:swissprot;acc:p06733]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 946\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent phosphoglycerate kinase 1 (ec 2.7.2.3) (primer recognition protein 2) (prp 2). [source:swissprot;acc:p00558]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6598.37\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7241.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.09744\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 947\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent signal transducing adaptor molecule 1; signal transducing adaptor molecule. [source:refseq;acc:nm\_003473]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 11797.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 10750.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.09738\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 948\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent caspase-7 precursor (ec 3.4.22.-) (ice-like apoptotic protease 3) (ice-lap3) (apoptotic protease mch-3) (cmh-1). [source:swissprot;acc:p55210]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 4633.48\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5084.24\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.09728\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 949\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent apopain precursor (ec 3.4.22.-) (cysteine protease cpp32) (yama protein) (cpp-32) (caspase-3) (casp-3) (srebp cleavage activity 1) (sca-1). [source:swissprot;acc:p42574]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 950\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent bystin. [source:swissprot;acc:q13895]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4280.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4697.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.09718\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 951\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dimethylaniline monooxygenase [n-oxide forming] 5 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 5) (fmo 5) (dimethylaniline oxidase 5). [source:swissprot;acc:p49326]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5364.3\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5885.48\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.09716\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 952\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent putative dimethylaniline monooxygenase [n-oxide forming] 6 (ec 1.14.13.8) (flavin-containing monooxygenase 6) (fmo 6) (dimethylaniline oxidase 6). [source:swissprot;acc:o60774]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 953\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent casein kinase i alpha s-like. [source:refseq;acc:nm\_145203]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 4906.33\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5382.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.09705\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 954\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent casein kinase i, alpha isoform (ec 2.7.1.-) (cki-alpha) (ck1). [source:swissprot;acc:p48729]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 955\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent uridine kinase-like 1. [source:swissprot;acc:q9nwz5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5548.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6086.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.09698\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 956\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dimethylaniline monooxygenase [n-oxide forming] 3 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 3) (fmo 3) (dimethylaniline oxidase 3) (fmo form 2) (fmo ii). [source:swissprot;acc:p31513]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5364.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5884.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.09695\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 957\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent structure-specific recognition protein 1 (ssrp1) (recombination signal sequence recognition protein) (t160) (chromatin-specific transcription elongation factor 80 kda subunit) (fact 80 kda subunit). [source:swissprot;acc:q08945]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 4483.26\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 4917.77\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.09692\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 958\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent chromatin-specific transcription elongation factor large subunit. [source:refseq;acc:nm\_007192]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 959\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sh2 domain binding protein 1; tpr-containing, sh2-binding phosphoprotein. [source:refseq;acc:nm\_014633]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4379.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4803.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.09689\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 960\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein kinase c, epsilon type (ec 2.7.1.-) (npkc-epsilon). [source:swissprot;acc:q02156]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 11773\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 10733.2\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.09688\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 961\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent peptidyl-prolyl cis-trans isomerase b precursor (ec 5.2.1.8) (ppiase) (rotamase) (cyclophilin b) (s-cyclophilin) (scylp) (cyp-s1). [source:swissprot;acc:p23284]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 962\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent udp-n-acetylglucosamine--peptide n-acetylglucosaminyltransferase 110 kda subunit (ec 2.4.1.-) (o-glcnac transferase p110 subunit). [source:swissprot;acc:o15294]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 963\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cytochrome c oxidase subunit iv isoform 1, mitochondrial precursor (ec 1.9.3.1) (cox iv-1) (cytochrome c oxidase polypeptide iv). [source:swissprot;acc:p13073]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 964\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cytochrome c oxidase subunit iv isoform 2, mitochondrial precursor (ec 1.9.3.1) (cox iv-2). [source:swissprot;acc:q96kj9]\vspace{3pt}}&&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 965\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein kinase c, eta type (ec 2.7.1.-) (npkc-eta) (pkc-l). [source:swissprot;acc:p24723]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 11773.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 10733.8\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 966\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent galectin-4 (lactose-binding lectin 4) (l-36 lactose binding protein) (l36lbp) (antigen ny-co-27). [source:swissprot;acc:p56470]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7817.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8575.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.09686\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 967\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein 4.1 (band 4.1) (p4.1) (epb4.1) (4.1r). [source:swissprot;acc:p11171]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7813.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8569.96\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.09684\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 968\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent spectrin beta chain, brain 4 (spectrin, non-erythroid beta chain 4) (beta-v spectrin) (bspecv). [source:swissprot;acc:q9nrc6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7813.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8570.11\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 969\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent band 4.1-like protein 1 (neuronal protein 4.1) (4.1n). [source:swissprot;acc:q9h4g0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7813.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8569.95\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 970\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent band 4.1-like protein 3 (4.1b) (differentially expressed in adenocarcinoma of the lung protein 1) (dal-1). [source:swissprot;acc:q9y2j2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7813.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8570.07\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 971\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent band 4.1-like protein 2 (generally expressed protein 4.1) (4.1g). [source:swissprot;acc:o43491]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7813.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8569.97\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 972\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 45 kda calcium-binding protein precursor (cab45) (stromal cell-derived factor 4) (sdf-4). [source:swissprot;acc:q9brk5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7813.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8570.11\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 973\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent galectin-9 (hom-hd-21) (ecalectin). [source:swissprot;acc:o00182]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7810.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8566.29\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.09682\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 974\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dimethylaniline monooxygenase [n-oxide forming] 2 (ec 1.14.13.8) (pulmonary flavin-containing monooxygenase 2) (fmo 2) (dimethylaniline oxidase 2) (fmo 1b1). [source:swissprot;acc:q99518]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5365.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5884.52\vspace{3pt}}&\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/